dihydroethidium has been researched along with Infarction, Middle Cerebral Artery in 6 studies
*Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalkara, T; Erdener, SE; Gursoy-Ozdemir, Y; Karatas, H; Taskiran-Sag, A; Yemisci, M; Yuce, D | 1 |
| Abe, K; Deguchi, K; Miyamoto, Y; Ohta, Y; Takamiya, M; Yamashita, T | 1 |
| Abe, K; Deguchi, K; Hayashi, T; Huh, NH; Kamiya, T; Miyazaki, M; Morimoto, N; Nagotani, S; Nakao, A; Ohta, Y; Sehara, Y; Tomiyama, K; Tsuchiya, A; Zhang, H | 1 |
| Liu, KJ; Liu, M; Liu, S; Miyake, M; Peterson, S; Vallyathan, V | 1 |
| Chan, PH; Sugawara, T; Yu, F | 1 |
| Horiuchi, M; Ishikawa, T; Iwai, M; Iwasaki, Y; Kuroda, S; Shichinohe, H; Yasuda, H | 1 |
6 other study(ies) available for dihydroethidium and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Improving Microcirculatory Reperfusion Reduces Parenchymal Oxygen Radical Formation and Provides Neuroprotection.
Topics: Animals; Benzenesulfonates; Blood-Brain Barrier; Cerebral Cortex; Cerebrovascular Circulation; Cyclic N-Oxides; Fluorescent Dyes; Infarction, Middle Cerebral Artery; Intravital Microscopy; Male; Mice; Microcirculation; Microscopy, Fluorescence; Neuroprotective Agents; Phenanthridines; Pia Mater; Reactive Oxygen Species; Reperfusion | 2018 |
Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.
Topics: Animals; Brain Infarction; Collagen Type IV; Disease Models, Animal; Drug Administration Schedule; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Matrix Metalloproteinase 9; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Movement Disorders; Phenanthridines; Platinum; Reactive Oxygen Species; Regional Blood Flow; Reperfusion; Spectroscopy, Near-Infrared; Superoxides; Time Factors; Tissue Plasminogen Activator | 2012 |
Reduction of cerebral infarction in rats by biliverdin associated with amelioration of oxidative stress.
Topics: Aldehydes; Animals; Antioxidants; Biliverdine; Cerebral Infarction; Disease Models, Animal; DNA Damage; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Male; Neurons; Neuroprotective Agents; Oxidative Stress; Phenanthridines; Rats; Rats, Wistar; Superoxides; Tetrazolium Salts; Treatment Outcome | 2008 |
Hydroxyl radical formation is greater in striatal core than in penumbra in a rat model of ischemic stroke.
Topics: Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis Solutions; Ethidium; Hydroxybenzoates; Hydroxyl Radical; Infarction, Middle Cerebral Artery; Microdialysis; Models, Animal; Parabens; Rats; Rats, Sprague-Dawley; Reperfusion | 2003 |
Treatment with dihydroethidium reduces infarct size after transient focal cerebral ischemia in mice.
Topics: Animals; Body Temperature; Brain Edema; Brain Mapping; Cerebral Infarction; Disease Models, Animal; Dose-Response Relationship, Drug; Ethidium; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Reperfusion Injury; Time Factors | 2003 |
Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia.
Topics: Animals; Antipyrine; Brain Ischemia; DNA-Binding Proteins; Edaravone; Ethidium; Free Radical Scavengers; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; Neuroprotective Agents; Nuclear Proteins; Reactive Oxygen Species; Superoxides | 2004 |